EUROPEAN JOURNAL OF MEDICAL RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2208357, encodeId=b8bc220835e73, content=请问大家，这个杂志发邮件说接收，然后就一直没让交版面费，并且一直发邮件说Publishing agreement form needs to be completed soon!然而，我们并没有收到相关的邮件，有遇到过的吗？Submission is in publishing and rights这个状态要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33fd5723184, createdName=ms1000000972447414, createdTime=Wed Jun 05 01:07:04 CST 2024, time=2024-06-05, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2235720, encodeId=842e2235e2079, content=2024.11.7收到期刊拒稿消息表示该期刊不考虑MR的文章，期刊原话： Specifically, the journal does not consider articles involving Mendelian Randomization., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Nov 07 16:15:19 CST 2024, time=2024-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2227544, encodeId=86d1222e544dd, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，审稿半年找不到审稿人被拒，避雷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed Sep 25 00:24:16 CST 2024, time=2024-09-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2221135, encodeId=17d32221135f2, content=被Scopus数据库剔除，下一步可能要被剔除sci了，审稿巨慢。而且可能要暴雷了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Sun Aug 18 16:41:27 CST 2024, time=2024-08-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182285, encodeId=8f4e2182285ee, content=等了6个月，返修之后又邀请了33个审稿人审稿，有毒吧。 Peer review Submission status Date Submission under peer review 17 Jan 2024 Submission passed technical check 17 Jan 2024 Revision received 16 Jan 2024 Submission under peer review 28 Jul 2023 Technical check Submission status Date Submission passed technical check 28 Jul 2023 Amendment received 26 Jul 2023 Submission is under technical check 24 Jul 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Wed Jan 17 20:19:25 CST 2024, time=2024-01-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189215, encodeId=852c218921579, content=生信+实验，这个杂志速度极其慢，2023.08.15Submission received，到现在已经半年了。中间发过几次邮件询问状态，都是官方回复。最后一次询问，被告知审稿已经完成，正在等待编辑决定。最后告诉我被拒了，并且没有发审稿意见，让我怀疑根本就没有送外审。前前后后拖了半年时间，希望大家看清这个杂志的情况，理性投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e6d5543991, createdName=逗你分分钟钟, createdTime=Sun Feb 25 08:27:27 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189678, encodeId=52fe21896e803, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：Editor assigned On 03 Nov, 2023 Submission checks complete On 02 Nov, 2023 First submitted to European Journal of Medical Research On 01 Nov, 2023 请问这个状态已经持续三个多月了，是还没找到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/de3a113eca6b05e9026a9c3b89b3031f.jpg, createdBy=f3002570394, createdName=无名者1123, createdTime=Tue Feb 27 16:05:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188692, encodeId=49102188692fa, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：历时四个月邀请了两个审稿人一审返修之后顺利通过Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 10 Feb 2024 Submission passed technical check 10 Feb 2024 Amendment received 09 Feb 2024 Revision received 09 Feb 2024 Submission under peer review 05 Dec 2023 Technical check Submission status Date Submission passed technical check 05 Dec 2023 Amendment received 05 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8865636856, createdName=ms6000000356171322, createdTime=Thu Feb 22 14:26:44 CST 2024, time=2024-02-22, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2175065, encodeId=6ab921e5065d1, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：周期非常长，9月份投稿，到现在还是邀请审稿人状态，还没开审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c41605662, createdName=folo, createdTime=Fri Dec 15 10:08:51 CST 2023, time=2023-12-15, status=1, ipAttribution=湖南省)]

2024-06-05 ms1000000972447414 来自新疆

请问大家，这个杂志发邮件说接收，然后就一直没让交版面费，并且一直发邮件说Publishing agreement form needs to be completed soon!然而，我们并没有收到相关的邮件，有遇到过的吗？Submission is in publishing and rights这个状态要多久呀？

75 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2208357, encodeId=b8bc220835e73, content=请问大家，这个杂志发邮件说接收，然后就一直没让交版面费，并且一直发邮件说Publishing agreement form needs to be completed soon!然而，我们并没有收到相关的邮件，有遇到过的吗？Submission is in publishing and rights这个状态要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33fd5723184, createdName=ms1000000972447414, createdTime=Wed Jun 05 01:07:04 CST 2024, time=2024-06-05, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2235720, encodeId=842e2235e2079, content=2024.11.7收到期刊拒稿消息表示该期刊不考虑MR的文章，期刊原话： Specifically, the journal does not consider articles involving Mendelian Randomization., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Nov 07 16:15:19 CST 2024, time=2024-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2227544, encodeId=86d1222e544dd, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，审稿半年找不到审稿人被拒，避雷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed Sep 25 00:24:16 CST 2024, time=2024-09-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2221135, encodeId=17d32221135f2, content=被Scopus数据库剔除，下一步可能要被剔除sci了，审稿巨慢。而且可能要暴雷了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Sun Aug 18 16:41:27 CST 2024, time=2024-08-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182285, encodeId=8f4e2182285ee, content=等了6个月，返修之后又邀请了33个审稿人审稿，有毒吧。 Peer review Submission status Date Submission under peer review 17 Jan 2024 Submission passed technical check 17 Jan 2024 Revision received 16 Jan 2024 Submission under peer review 28 Jul 2023 Technical check Submission status Date Submission passed technical check 28 Jul 2023 Amendment received 26 Jul 2023 Submission is under technical check 24 Jul 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Wed Jan 17 20:19:25 CST 2024, time=2024-01-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189215, encodeId=852c218921579, content=生信+实验，这个杂志速度极其慢，2023.08.15Submission received，到现在已经半年了。中间发过几次邮件询问状态，都是官方回复。最后一次询问，被告知审稿已经完成，正在等待编辑决定。最后告诉我被拒了，并且没有发审稿意见，让我怀疑根本就没有送外审。前前后后拖了半年时间，希望大家看清这个杂志的情况，理性投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e6d5543991, createdName=逗你分分钟钟, createdTime=Sun Feb 25 08:27:27 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189678, encodeId=52fe21896e803, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：Editor assigned On 03 Nov, 2023 Submission checks complete On 02 Nov, 2023 First submitted to European Journal of Medical Research On 01 Nov, 2023 请问这个状态已经持续三个多月了，是还没找到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/de3a113eca6b05e9026a9c3b89b3031f.jpg, createdBy=f3002570394, createdName=无名者1123, createdTime=Tue Feb 27 16:05:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188692, encodeId=49102188692fa, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：历时四个月邀请了两个审稿人一审返修之后顺利通过Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 10 Feb 2024 Submission passed technical check 10 Feb 2024 Amendment received 09 Feb 2024 Revision received 09 Feb 2024 Submission under peer review 05 Dec 2023 Technical check Submission status Date Submission passed technical check 05 Dec 2023 Amendment received 05 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8865636856, createdName=ms6000000356171322, createdTime=Thu Feb 22 14:26:44 CST 2024, time=2024-02-22, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2175065, encodeId=6ab921e5065d1, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：周期非常长，9月份投稿，到现在还是邀请审稿人状态，还没开审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c41605662, createdName=folo, createdTime=Fri Dec 15 10:08:51 CST 2023, time=2023-12-15, status=1, ipAttribution=湖南省)]

2024-11-07 匿名用户

2024.11.7收到期刊拒稿消息表示该期刊不考虑MR的文章，期刊原话： Specifically, the journal does not consider articles involving Mendelian Randomization.

33 0

[GetPortalCommentsPageByObjectIdResponse(id=2208357, encodeId=b8bc220835e73, content=请问大家，这个杂志发邮件说接收，然后就一直没让交版面费，并且一直发邮件说Publishing agreement form needs to be completed soon!然而，我们并没有收到相关的邮件，有遇到过的吗？Submission is in publishing and rights这个状态要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33fd5723184, createdName=ms1000000972447414, createdTime=Wed Jun 05 01:07:04 CST 2024, time=2024-06-05, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2235720, encodeId=842e2235e2079, content=2024.11.7收到期刊拒稿消息表示该期刊不考虑MR的文章，期刊原话： Specifically, the journal does not consider articles involving Mendelian Randomization., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Nov 07 16:15:19 CST 2024, time=2024-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2227544, encodeId=86d1222e544dd, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，审稿半年找不到审稿人被拒，避雷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed Sep 25 00:24:16 CST 2024, time=2024-09-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2221135, encodeId=17d32221135f2, content=被Scopus数据库剔除，下一步可能要被剔除sci了，审稿巨慢。而且可能要暴雷了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Sun Aug 18 16:41:27 CST 2024, time=2024-08-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182285, encodeId=8f4e2182285ee, content=等了6个月，返修之后又邀请了33个审稿人审稿，有毒吧。 Peer review Submission status Date Submission under peer review 17 Jan 2024 Submission passed technical check 17 Jan 2024 Revision received 16 Jan 2024 Submission under peer review 28 Jul 2023 Technical check Submission status Date Submission passed technical check 28 Jul 2023 Amendment received 26 Jul 2023 Submission is under technical check 24 Jul 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Wed Jan 17 20:19:25 CST 2024, time=2024-01-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189215, encodeId=852c218921579, content=生信+实验，这个杂志速度极其慢，2023.08.15Submission received，到现在已经半年了。中间发过几次邮件询问状态，都是官方回复。最后一次询问，被告知审稿已经完成，正在等待编辑决定。最后告诉我被拒了，并且没有发审稿意见，让我怀疑根本就没有送外审。前前后后拖了半年时间，希望大家看清这个杂志的情况，理性投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e6d5543991, createdName=逗你分分钟钟, createdTime=Sun Feb 25 08:27:27 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189678, encodeId=52fe21896e803, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：Editor assigned On 03 Nov, 2023 Submission checks complete On 02 Nov, 2023 First submitted to European Journal of Medical Research On 01 Nov, 2023 请问这个状态已经持续三个多月了，是还没找到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/de3a113eca6b05e9026a9c3b89b3031f.jpg, createdBy=f3002570394, createdName=无名者1123, createdTime=Tue Feb 27 16:05:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188692, encodeId=49102188692fa, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：历时四个月邀请了两个审稿人一审返修之后顺利通过Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 10 Feb 2024 Submission passed technical check 10 Feb 2024 Amendment received 09 Feb 2024 Revision received 09 Feb 2024 Submission under peer review 05 Dec 2023 Technical check Submission status Date Submission passed technical check 05 Dec 2023 Amendment received 05 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8865636856, createdName=ms6000000356171322, createdTime=Thu Feb 22 14:26:44 CST 2024, time=2024-02-22, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2175065, encodeId=6ab921e5065d1, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：周期非常长，9月份投稿，到现在还是邀请审稿人状态，还没开审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c41605662, createdName=folo, createdTime=Fri Dec 15 10:08:51 CST 2023, time=2023-12-15, status=1, ipAttribution=湖南省)]

2024-09-25 ms7000000417591078 来自天津

审稿速度:12.0 | 投稿命中率:5.0
偏重的研究方向：肿瘤
经验分享：垃圾杂志，审稿半年找不到审稿人被拒，避雷

32 0

[GetPortalCommentsPageByObjectIdResponse(id=2208357, encodeId=b8bc220835e73, content=请问大家，这个杂志发邮件说接收，然后就一直没让交版面费，并且一直发邮件说Publishing agreement form needs to be completed soon!然而，我们并没有收到相关的邮件，有遇到过的吗？Submission is in publishing and rights这个状态要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33fd5723184, createdName=ms1000000972447414, createdTime=Wed Jun 05 01:07:04 CST 2024, time=2024-06-05, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2235720, encodeId=842e2235e2079, content=2024.11.7收到期刊拒稿消息表示该期刊不考虑MR的文章，期刊原话： Specifically, the journal does not consider articles involving Mendelian Randomization., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Nov 07 16:15:19 CST 2024, time=2024-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2227544, encodeId=86d1222e544dd, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，审稿半年找不到审稿人被拒，避雷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed Sep 25 00:24:16 CST 2024, time=2024-09-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2221135, encodeId=17d32221135f2, content=被Scopus数据库剔除，下一步可能要被剔除sci了，审稿巨慢。而且可能要暴雷了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Sun Aug 18 16:41:27 CST 2024, time=2024-08-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182285, encodeId=8f4e2182285ee, content=等了6个月，返修之后又邀请了33个审稿人审稿，有毒吧。 Peer review Submission status Date Submission under peer review 17 Jan 2024 Submission passed technical check 17 Jan 2024 Revision received 16 Jan 2024 Submission under peer review 28 Jul 2023 Technical check Submission status Date Submission passed technical check 28 Jul 2023 Amendment received 26 Jul 2023 Submission is under technical check 24 Jul 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Wed Jan 17 20:19:25 CST 2024, time=2024-01-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189215, encodeId=852c218921579, content=生信+实验，这个杂志速度极其慢，2023.08.15Submission received，到现在已经半年了。中间发过几次邮件询问状态，都是官方回复。最后一次询问，被告知审稿已经完成，正在等待编辑决定。最后告诉我被拒了，并且没有发审稿意见，让我怀疑根本就没有送外审。前前后后拖了半年时间，希望大家看清这个杂志的情况，理性投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e6d5543991, createdName=逗你分分钟钟, createdTime=Sun Feb 25 08:27:27 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189678, encodeId=52fe21896e803, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：Editor assigned On 03 Nov, 2023 Submission checks complete On 02 Nov, 2023 First submitted to European Journal of Medical Research On 01 Nov, 2023 请问这个状态已经持续三个多月了，是还没找到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/de3a113eca6b05e9026a9c3b89b3031f.jpg, createdBy=f3002570394, createdName=无名者1123, createdTime=Tue Feb 27 16:05:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188692, encodeId=49102188692fa, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：历时四个月邀请了两个审稿人一审返修之后顺利通过Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 10 Feb 2024 Submission passed technical check 10 Feb 2024 Amendment received 09 Feb 2024 Revision received 09 Feb 2024 Submission under peer review 05 Dec 2023 Technical check Submission status Date Submission passed technical check 05 Dec 2023 Amendment received 05 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8865636856, createdName=ms6000000356171322, createdTime=Thu Feb 22 14:26:44 CST 2024, time=2024-02-22, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2175065, encodeId=6ab921e5065d1, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：周期非常长，9月份投稿，到现在还是邀请审稿人状态，还没开审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c41605662, createdName=folo, createdTime=Fri Dec 15 10:08:51 CST 2023, time=2023-12-15, status=1, ipAttribution=湖南省)]

2024-08-18 ms7000000417591078 来自天津

被Scopus数据库剔除，下一步可能要被剔除sci了，审稿巨慢。而且可能要暴雷了

113 0

[GetPortalCommentsPageByObjectIdResponse(id=2208357, encodeId=b8bc220835e73, content=请问大家，这个杂志发邮件说接收，然后就一直没让交版面费，并且一直发邮件说Publishing agreement form needs to be completed soon!然而，我们并没有收到相关的邮件，有遇到过的吗？Submission is in publishing and rights这个状态要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33fd5723184, createdName=ms1000000972447414, createdTime=Wed Jun 05 01:07:04 CST 2024, time=2024-06-05, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2235720, encodeId=842e2235e2079, content=2024.11.7收到期刊拒稿消息表示该期刊不考虑MR的文章，期刊原话： Specifically, the journal does not consider articles involving Mendelian Randomization., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Nov 07 16:15:19 CST 2024, time=2024-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2227544, encodeId=86d1222e544dd, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，审稿半年找不到审稿人被拒，避雷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed Sep 25 00:24:16 CST 2024, time=2024-09-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2221135, encodeId=17d32221135f2, content=被Scopus数据库剔除，下一步可能要被剔除sci了，审稿巨慢。而且可能要暴雷了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Sun Aug 18 16:41:27 CST 2024, time=2024-08-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182285, encodeId=8f4e2182285ee, content=等了6个月，返修之后又邀请了33个审稿人审稿，有毒吧。 Peer review Submission status Date Submission under peer review 17 Jan 2024 Submission passed technical check 17 Jan 2024 Revision received 16 Jan 2024 Submission under peer review 28 Jul 2023 Technical check Submission status Date Submission passed technical check 28 Jul 2023 Amendment received 26 Jul 2023 Submission is under technical check 24 Jul 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Wed Jan 17 20:19:25 CST 2024, time=2024-01-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189215, encodeId=852c218921579, content=生信+实验，这个杂志速度极其慢，2023.08.15Submission received，到现在已经半年了。中间发过几次邮件询问状态，都是官方回复。最后一次询问，被告知审稿已经完成，正在等待编辑决定。最后告诉我被拒了，并且没有发审稿意见，让我怀疑根本就没有送外审。前前后后拖了半年时间，希望大家看清这个杂志的情况，理性投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e6d5543991, createdName=逗你分分钟钟, createdTime=Sun Feb 25 08:27:27 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189678, encodeId=52fe21896e803, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：Editor assigned On 03 Nov, 2023 Submission checks complete On 02 Nov, 2023 First submitted to European Journal of Medical Research On 01 Nov, 2023 请问这个状态已经持续三个多月了，是还没找到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/de3a113eca6b05e9026a9c3b89b3031f.jpg, createdBy=f3002570394, createdName=无名者1123, createdTime=Tue Feb 27 16:05:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188692, encodeId=49102188692fa, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：历时四个月邀请了两个审稿人一审返修之后顺利通过Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 10 Feb 2024 Submission passed technical check 10 Feb 2024 Amendment received 09 Feb 2024 Revision received 09 Feb 2024 Submission under peer review 05 Dec 2023 Technical check Submission status Date Submission passed technical check 05 Dec 2023 Amendment received 05 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8865636856, createdName=ms6000000356171322, createdTime=Thu Feb 22 14:26:44 CST 2024, time=2024-02-22, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2175065, encodeId=6ab921e5065d1, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：周期非常长，9月份投稿，到现在还是邀请审稿人状态，还没开审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c41605662, createdName=folo, createdTime=Fri Dec 15 10:08:51 CST 2023, time=2023-12-15, status=1, ipAttribution=湖南省)]

2024-01-12 ms9000000801374228 来自广东省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：临床
经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2208357, encodeId=b8bc220835e73, content=请问大家，这个杂志发邮件说接收，然后就一直没让交版面费，并且一直发邮件说Publishing agreement form needs to be completed soon!然而，我们并没有收到相关的邮件，有遇到过的吗？Submission is in publishing and rights这个状态要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33fd5723184, createdName=ms1000000972447414, createdTime=Wed Jun 05 01:07:04 CST 2024, time=2024-06-05, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2235720, encodeId=842e2235e2079, content=2024.11.7收到期刊拒稿消息表示该期刊不考虑MR的文章，期刊原话： Specifically, the journal does not consider articles involving Mendelian Randomization., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Nov 07 16:15:19 CST 2024, time=2024-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2227544, encodeId=86d1222e544dd, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，审稿半年找不到审稿人被拒，避雷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed Sep 25 00:24:16 CST 2024, time=2024-09-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2221135, encodeId=17d32221135f2, content=被Scopus数据库剔除，下一步可能要被剔除sci了，审稿巨慢。而且可能要暴雷了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Sun Aug 18 16:41:27 CST 2024, time=2024-08-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182285, encodeId=8f4e2182285ee, content=等了6个月，返修之后又邀请了33个审稿人审稿，有毒吧。 Peer review Submission status Date Submission under peer review 17 Jan 2024 Submission passed technical check 17 Jan 2024 Revision received 16 Jan 2024 Submission under peer review 28 Jul 2023 Technical check Submission status Date Submission passed technical check 28 Jul 2023 Amendment received 26 Jul 2023 Submission is under technical check 24 Jul 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Wed Jan 17 20:19:25 CST 2024, time=2024-01-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189215, encodeId=852c218921579, content=生信+实验，这个杂志速度极其慢，2023.08.15Submission received，到现在已经半年了。中间发过几次邮件询问状态，都是官方回复。最后一次询问，被告知审稿已经完成，正在等待编辑决定。最后告诉我被拒了，并且没有发审稿意见，让我怀疑根本就没有送外审。前前后后拖了半年时间，希望大家看清这个杂志的情况，理性投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e6d5543991, createdName=逗你分分钟钟, createdTime=Sun Feb 25 08:27:27 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189678, encodeId=52fe21896e803, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：Editor assigned On 03 Nov, 2023 Submission checks complete On 02 Nov, 2023 First submitted to European Journal of Medical Research On 01 Nov, 2023 请问这个状态已经持续三个多月了，是还没找到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/de3a113eca6b05e9026a9c3b89b3031f.jpg, createdBy=f3002570394, createdName=无名者1123, createdTime=Tue Feb 27 16:05:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188692, encodeId=49102188692fa, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：历时四个月邀请了两个审稿人一审返修之后顺利通过Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 10 Feb 2024 Submission passed technical check 10 Feb 2024 Amendment received 09 Feb 2024 Revision received 09 Feb 2024 Submission under peer review 05 Dec 2023 Technical check Submission status Date Submission passed technical check 05 Dec 2023 Amendment received 05 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8865636856, createdName=ms6000000356171322, createdTime=Thu Feb 22 14:26:44 CST 2024, time=2024-02-22, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2175065, encodeId=6ab921e5065d1, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：周期非常长，9月份投稿，到现在还是邀请审稿人状态，还没开审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c41605662, createdName=folo, createdTime=Fri Dec 15 10:08:51 CST 2023, time=2023-12-15, status=1, ipAttribution=湖南省)]

2024-01-17 huahaha 来自广西

等了6个月，返修之后又邀请了33个审稿人审稿，有毒吧。

Peer review
Submission status Date
Submission under peer review
17 Jan 2024
Submission passed technical check
17 Jan 2024
Revision received
16 Jan 2024
Submission under peer review
28 Jul 2023
Technical check
Submission status Date
Submission passed technical check
28 Jul 2023
Amendment received
26 Jul 2023
Submission is under technical check
24 Jul 2023

152 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2208357, encodeId=b8bc220835e73, content=请问大家，这个杂志发邮件说接收，然后就一直没让交版面费，并且一直发邮件说Publishing agreement form needs to be completed soon!然而，我们并没有收到相关的邮件，有遇到过的吗？Submission is in publishing and rights这个状态要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33fd5723184, createdName=ms1000000972447414, createdTime=Wed Jun 05 01:07:04 CST 2024, time=2024-06-05, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2235720, encodeId=842e2235e2079, content=2024.11.7收到期刊拒稿消息表示该期刊不考虑MR的文章，期刊原话： Specifically, the journal does not consider articles involving Mendelian Randomization., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Nov 07 16:15:19 CST 2024, time=2024-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2227544, encodeId=86d1222e544dd, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，审稿半年找不到审稿人被拒，避雷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed Sep 25 00:24:16 CST 2024, time=2024-09-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2221135, encodeId=17d32221135f2, content=被Scopus数据库剔除，下一步可能要被剔除sci了，审稿巨慢。而且可能要暴雷了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Sun Aug 18 16:41:27 CST 2024, time=2024-08-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182285, encodeId=8f4e2182285ee, content=等了6个月，返修之后又邀请了33个审稿人审稿，有毒吧。 Peer review Submission status Date Submission under peer review 17 Jan 2024 Submission passed technical check 17 Jan 2024 Revision received 16 Jan 2024 Submission under peer review 28 Jul 2023 Technical check Submission status Date Submission passed technical check 28 Jul 2023 Amendment received 26 Jul 2023 Submission is under technical check 24 Jul 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Wed Jan 17 20:19:25 CST 2024, time=2024-01-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189215, encodeId=852c218921579, content=生信+实验，这个杂志速度极其慢，2023.08.15Submission received，到现在已经半年了。中间发过几次邮件询问状态，都是官方回复。最后一次询问，被告知审稿已经完成，正在等待编辑决定。最后告诉我被拒了，并且没有发审稿意见，让我怀疑根本就没有送外审。前前后后拖了半年时间，希望大家看清这个杂志的情况，理性投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e6d5543991, createdName=逗你分分钟钟, createdTime=Sun Feb 25 08:27:27 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189678, encodeId=52fe21896e803, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：Editor assigned On 03 Nov, 2023 Submission checks complete On 02 Nov, 2023 First submitted to European Journal of Medical Research On 01 Nov, 2023 请问这个状态已经持续三个多月了，是还没找到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/de3a113eca6b05e9026a9c3b89b3031f.jpg, createdBy=f3002570394, createdName=无名者1123, createdTime=Tue Feb 27 16:05:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188692, encodeId=49102188692fa, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：历时四个月邀请了两个审稿人一审返修之后顺利通过Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 10 Feb 2024 Submission passed technical check 10 Feb 2024 Amendment received 09 Feb 2024 Revision received 09 Feb 2024 Submission under peer review 05 Dec 2023 Technical check Submission status Date Submission passed technical check 05 Dec 2023 Amendment received 05 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8865636856, createdName=ms6000000356171322, createdTime=Thu Feb 22 14:26:44 CST 2024, time=2024-02-22, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2175065, encodeId=6ab921e5065d1, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：周期非常长，9月份投稿，到现在还是邀请审稿人状态，还没开审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c41605662, createdName=folo, createdTime=Fri Dec 15 10:08:51 CST 2023, time=2023-12-15, status=1, ipAttribution=湖南省)]

2024-02-25 逗你分分钟钟来自北京

生信+实验，这个杂志速度极其慢，2023.08.15Submission received，到现在已经半年了。中间发过几次邮件询问状态，都是官方回复。最后一次询问，被告知审稿已经完成，正在等待编辑决定。最后告诉我被拒了，并且没有发审稿意见，让我怀疑根本就没有送外审。前前后后拖了半年时间，希望大家看清这个杂志的情况，理性投稿。

107 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2208357, encodeId=b8bc220835e73, content=请问大家，这个杂志发邮件说接收，然后就一直没让交版面费，并且一直发邮件说Publishing agreement form needs to be completed soon!然而，我们并没有收到相关的邮件，有遇到过的吗？Submission is in publishing and rights这个状态要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33fd5723184, createdName=ms1000000972447414, createdTime=Wed Jun 05 01:07:04 CST 2024, time=2024-06-05, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2235720, encodeId=842e2235e2079, content=2024.11.7收到期刊拒稿消息表示该期刊不考虑MR的文章，期刊原话： Specifically, the journal does not consider articles involving Mendelian Randomization., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Nov 07 16:15:19 CST 2024, time=2024-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2227544, encodeId=86d1222e544dd, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，审稿半年找不到审稿人被拒，避雷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed Sep 25 00:24:16 CST 2024, time=2024-09-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2221135, encodeId=17d32221135f2, content=被Scopus数据库剔除，下一步可能要被剔除sci了，审稿巨慢。而且可能要暴雷了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Sun Aug 18 16:41:27 CST 2024, time=2024-08-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182285, encodeId=8f4e2182285ee, content=等了6个月，返修之后又邀请了33个审稿人审稿，有毒吧。 Peer review Submission status Date Submission under peer review 17 Jan 2024 Submission passed technical check 17 Jan 2024 Revision received 16 Jan 2024 Submission under peer review 28 Jul 2023 Technical check Submission status Date Submission passed technical check 28 Jul 2023 Amendment received 26 Jul 2023 Submission is under technical check 24 Jul 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Wed Jan 17 20:19:25 CST 2024, time=2024-01-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189215, encodeId=852c218921579, content=生信+实验，这个杂志速度极其慢，2023.08.15Submission received，到现在已经半年了。中间发过几次邮件询问状态，都是官方回复。最后一次询问，被告知审稿已经完成，正在等待编辑决定。最后告诉我被拒了，并且没有发审稿意见，让我怀疑根本就没有送外审。前前后后拖了半年时间，希望大家看清这个杂志的情况，理性投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e6d5543991, createdName=逗你分分钟钟, createdTime=Sun Feb 25 08:27:27 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189678, encodeId=52fe21896e803, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：Editor assigned On 03 Nov, 2023 Submission checks complete On 02 Nov, 2023 First submitted to European Journal of Medical Research On 01 Nov, 2023 请问这个状态已经持续三个多月了，是还没找到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/de3a113eca6b05e9026a9c3b89b3031f.jpg, createdBy=f3002570394, createdName=无名者1123, createdTime=Tue Feb 27 16:05:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188692, encodeId=49102188692fa, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：历时四个月邀请了两个审稿人一审返修之后顺利通过Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 10 Feb 2024 Submission passed technical check 10 Feb 2024 Amendment received 09 Feb 2024 Revision received 09 Feb 2024 Submission under peer review 05 Dec 2023 Technical check Submission status Date Submission passed technical check 05 Dec 2023 Amendment received 05 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8865636856, createdName=ms6000000356171322, createdTime=Thu Feb 22 14:26:44 CST 2024, time=2024-02-22, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2175065, encodeId=6ab921e5065d1, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：周期非常长，9月份投稿，到现在还是邀请审稿人状态，还没开审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c41605662, createdName=folo, createdTime=Fri Dec 15 10:08:51 CST 2023, time=2023-12-15, status=1, ipAttribution=湖南省)]

2024-02-27 无名者1123 来自湖北省

审稿速度:24.0 | 投稿命中率:25.0
经验分享：Editor assigned
On 03 Nov, 2023
Submission checks complete
On 02 Nov, 2023
First submitted to European Journal of Medical Research
On 01 Nov, 2023
请问这个状态已经持续三个多月了，是还没找到编辑吗

102 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2208357, encodeId=b8bc220835e73, content=请问大家，这个杂志发邮件说接收，然后就一直没让交版面费，并且一直发邮件说Publishing agreement form needs to be completed soon!然而，我们并没有收到相关的邮件，有遇到过的吗？Submission is in publishing and rights这个状态要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33fd5723184, createdName=ms1000000972447414, createdTime=Wed Jun 05 01:07:04 CST 2024, time=2024-06-05, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2235720, encodeId=842e2235e2079, content=2024.11.7收到期刊拒稿消息表示该期刊不考虑MR的文章，期刊原话： Specifically, the journal does not consider articles involving Mendelian Randomization., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Nov 07 16:15:19 CST 2024, time=2024-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2227544, encodeId=86d1222e544dd, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，审稿半年找不到审稿人被拒，避雷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed Sep 25 00:24:16 CST 2024, time=2024-09-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2221135, encodeId=17d32221135f2, content=被Scopus数据库剔除，下一步可能要被剔除sci了，审稿巨慢。而且可能要暴雷了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Sun Aug 18 16:41:27 CST 2024, time=2024-08-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182285, encodeId=8f4e2182285ee, content=等了6个月，返修之后又邀请了33个审稿人审稿，有毒吧。 Peer review Submission status Date Submission under peer review 17 Jan 2024 Submission passed technical check 17 Jan 2024 Revision received 16 Jan 2024 Submission under peer review 28 Jul 2023 Technical check Submission status Date Submission passed technical check 28 Jul 2023 Amendment received 26 Jul 2023 Submission is under technical check 24 Jul 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Wed Jan 17 20:19:25 CST 2024, time=2024-01-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189215, encodeId=852c218921579, content=生信+实验，这个杂志速度极其慢，2023.08.15Submission received，到现在已经半年了。中间发过几次邮件询问状态，都是官方回复。最后一次询问，被告知审稿已经完成，正在等待编辑决定。最后告诉我被拒了，并且没有发审稿意见，让我怀疑根本就没有送外审。前前后后拖了半年时间，希望大家看清这个杂志的情况，理性投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e6d5543991, createdName=逗你分分钟钟, createdTime=Sun Feb 25 08:27:27 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189678, encodeId=52fe21896e803, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：Editor assigned On 03 Nov, 2023 Submission checks complete On 02 Nov, 2023 First submitted to European Journal of Medical Research On 01 Nov, 2023 请问这个状态已经持续三个多月了，是还没找到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/de3a113eca6b05e9026a9c3b89b3031f.jpg, createdBy=f3002570394, createdName=无名者1123, createdTime=Tue Feb 27 16:05:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188692, encodeId=49102188692fa, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：历时四个月邀请了两个审稿人一审返修之后顺利通过Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 10 Feb 2024 Submission passed technical check 10 Feb 2024 Amendment received 09 Feb 2024 Revision received 09 Feb 2024 Submission under peer review 05 Dec 2023 Technical check Submission status Date Submission passed technical check 05 Dec 2023 Amendment received 05 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8865636856, createdName=ms6000000356171322, createdTime=Thu Feb 22 14:26:44 CST 2024, time=2024-02-22, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2175065, encodeId=6ab921e5065d1, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：周期非常长，9月份投稿，到现在还是邀请审稿人状态，还没开审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c41605662, createdName=folo, createdTime=Fri Dec 15 10:08:51 CST 2023, time=2023-12-15, status=1, ipAttribution=湖南省)]

2024-02-22 ms6000000356171322 来自吉林省

审稿速度:6.0 | 投稿命中率:95.0
偏重的研究方向：糖尿病
经验分享：历时四个月邀请了两个审稿人一审返修之后顺利通过Submission status Date
Submission accepted
21 Feb 2024
Submission under peer review
10 Feb 2024
Submission passed technical check
10 Feb 2024
Amendment received
09 Feb 2024
Revision received
09 Feb 2024
Submission under peer review
05 Dec 2023
Technical check
Submission status Date
Submission passed technical check
05 Dec 2023
Amendment received
05 Dec 2023
Submission is under technical check
04 Dec 2023
Submission received
Submission status Date
Submission received
04 Dec 2023

112 0

[GetPortalCommentsPageByObjectIdResponse(id=2208357, encodeId=b8bc220835e73, content=请问大家，这个杂志发邮件说接收，然后就一直没让交版面费，并且一直发邮件说Publishing agreement form needs to be completed soon!然而，我们并没有收到相关的邮件，有遇到过的吗？Submission is in publishing and rights这个状态要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33fd5723184, createdName=ms1000000972447414, createdTime=Wed Jun 05 01:07:04 CST 2024, time=2024-06-05, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2235720, encodeId=842e2235e2079, content=2024.11.7收到期刊拒稿消息表示该期刊不考虑MR的文章，期刊原话： Specifically, the journal does not consider articles involving Mendelian Randomization., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Nov 07 16:15:19 CST 2024, time=2024-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2227544, encodeId=86d1222e544dd, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：垃圾杂志，审稿半年找不到审稿人被拒，避雷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed Sep 25 00:24:16 CST 2024, time=2024-09-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2221135, encodeId=17d32221135f2, content=被Scopus数据库剔除，下一步可能要被剔除sci了，审稿巨慢。而且可能要暴雷了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Sun Aug 18 16:41:27 CST 2024, time=2024-08-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2181030, encodeId=7360218103046, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：2个月的时候返修了，然后返修到现在三个多月了，催了也没进展，真的太慢了。等到心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f68637422, createdName=ms9000000801374228, createdTime=Fri Jan 12 18:11:26 CST 2024, time=2024-01-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182285, encodeId=8f4e2182285ee, content=等了6个月，返修之后又邀请了33个审稿人审稿，有毒吧。 Peer review Submission status Date Submission under peer review 17 Jan 2024 Submission passed technical check 17 Jan 2024 Revision received 16 Jan 2024 Submission under peer review 28 Jul 2023 Technical check Submission status Date Submission passed technical check 28 Jul 2023 Amendment received 26 Jul 2023 Submission is under technical check 24 Jul 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/05tPoOriam2U5UQB0v594rPQgFsCeTZgGbca62Lakvib8siboLpYqgE5JQQTrr5VHibHMsouLWKiaRWObHAynlYj26Q/132, createdBy=1a7c2030420, createdName=huahaha, createdTime=Wed Jan 17 20:19:25 CST 2024, time=2024-01-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2189215, encodeId=852c218921579, content=生信+实验，这个杂志速度极其慢，2023.08.15Submission received，到现在已经半年了。中间发过几次邮件询问状态，都是官方回复。最后一次询问，被告知审稿已经完成，正在等待编辑决定。最后告诉我被拒了，并且没有发审稿意见，让我怀疑根本就没有送外审。前前后后拖了半年时间，希望大家看清这个杂志的情况，理性投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e6d5543991, createdName=逗你分分钟钟, createdTime=Sun Feb 25 08:27:27 CST 2024, time=2024-02-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189678, encodeId=52fe21896e803, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：Editor assigned On 03 Nov, 2023 Submission checks complete On 02 Nov, 2023 First submitted to European Journal of Medical Research On 01 Nov, 2023 请问这个状态已经持续三个多月了，是还没找到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/de3a113eca6b05e9026a9c3b89b3031f.jpg, createdBy=f3002570394, createdName=无名者1123, createdTime=Tue Feb 27 16:05:26 CST 2024, time=2024-02-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2188692, encodeId=49102188692fa, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：历时四个月邀请了两个审稿人一审返修之后顺利通过Submission status Date Submission accepted 21 Feb 2024 Submission under peer review 10 Feb 2024 Submission passed technical check 10 Feb 2024 Amendment received 09 Feb 2024 Revision received 09 Feb 2024 Submission under peer review 05 Dec 2023 Technical check Submission status Date Submission passed technical check 05 Dec 2023 Amendment received 05 Dec 2023 Submission is under technical check 04 Dec 2023 Submission received Submission status Date Submission received 04 Dec 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8865636856, createdName=ms6000000356171322, createdTime=Thu Feb 22 14:26:44 CST 2024, time=2024-02-22, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2175065, encodeId=6ab921e5065d1, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：周期非常长，9月份投稿，到现在还是邀请审稿人状态，还没开审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c41605662, createdName=folo, createdTime=Fri Dec 15 10:08:51 CST 2023, time=2023-12-15, status=1, ipAttribution=湖南省)]

2023-12-15 folo 来自湖南省

审稿速度:24.0 | 投稿命中率:5.0
经验分享：周期非常长，9月份投稿，到现在还是邀请审稿人状态，还没开审稿

116 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务